| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1372770 | Bioorganic & Medicinal Chemistry Letters | 2011 | 5 Pages |
Most ischemic stroke results from brain blood vessel blockage by platelet-mediated thrombus, and anti-platelet therapy has been demonstrated clinical benefits in the treatment of this disease. In the present work, novel nitric oxide (NO)-releasing derivatives of an anti-ischemic stroke drug 3-n-butylphthalide (NBP) were synthesized. Compounds 7a and 7c exhibited more potent anti-platelet activity than NBP and aspirin, and released a moderate amount of NO, which is beneficial in improving cardiovascular and cerebral circulation. These findings provide an alternative approach to the development of drugs more potent than NBP for the intervention of ischemic stroke.
Graphical abstractA series of novel nitric oxide (NO)-releasing derivatives of an anti-ischemic stroke drug 3-n-butylphthalide (NO-NBP) were synthesized and evaluated for their anti-platelet activity and NO releasing ability.Figure optionsDownload full-size imageDownload as PowerPoint slide
